Carlos Villa Joins Versiti Blood Research Institute
Versiti Blood Research Institute shared on LinkedIn:
”Please welcome Carlos Villa, MD, PhD to VBRI!
Carlos Villa is joining the Translational Hematology Program as a Transfusion Medicine Clinician Investigator.
He joins Versiti from the US Food and Drug Administration where, most recently, he was the Associate Director for Special Programs in the Office of Blood Research and Review at CBER.
In that role, he contributed to regulatory, policy, and research initiatives to advance the safety and effectiveness of blood and blood components.
His clinical background is in Clinical Pathology and Transfusion Medicine, and his research has spanned basic sciences to clinical medicine, with experience in pharmacology and drug delivery.
He completed his MD/PhD training at the Tri Institutional program at Weill Cornell and Memorial Sloan Kettering, which was followed by residency and fellowship training at the University of Pennsylvania.”
Stay updated with Hemostasis Today.
-
May 25, 2026, 05:25Abdullah Mohsin: Automated Detection of DVT Using Deep Learning and Doppler Ultrasound
-
May 25, 2026, 05:07The Dual Role of PAI-1 Mutations in Bleeding and Thrombotic Disorders – ICHCC
-
May 25, 2026, 05:04Fibrinogen αC Domain Lysines Drive Plasminogen Binding and Plasmin Generation – JTH
-
May 25, 2026, 04:50Gülşah Türkoğlu: An Encouraging Momentum Around the Adoption of Resolutions on Stroke Care at WHA79
-
May 25, 2026, 04:47Krishnakant Prasad: A Quick Clinical Review of Renal Papillary Necrosis
-
May 25, 2026, 04:40Rajiv Kumar Jain: World Health Assembly Adopts First-Ever Global Resolution on Stroke Prevention and Care
-
May 25, 2026, 04:23Sarfraz Ahmad: Diagnostic and Therapeutic Challenges in ICA Aneurysm Presenting With Epistaxis
-
May 24, 2026, 17:48Flora Peyvandi: Crucial Role of Placental ADAMTS13 in Perinatal Survival
-
May 24, 2026, 17:13Mahtab Mashayekhi: The Evolving Role of Red Blood Cell Exchange in the Management of SCD